Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BergaMet North America is a private U.S. consumer health and nutraceutical company focused on citrus bergamot-based dietary supplements sourced from Calabria, Italy. The company markets commercially available products aimed at cholesterol support, cardiovascular wellness, metabolic and glucose balance, performance, sleep, hydration, and healthy aging. Its portfolio is built around standardized bergamot polyphenol extracts rather than prescription therapeutics, and it appears to operate as a direct-to-consumer wellness brand rather than a clinical-stage biotech or pharmaceutical developer. Publicly available materials indicate an active commercial operation in the United States, with products sold online under the BergaMet brand.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BergaMet North America.